Last Updated:
2:55 pm
Wednesday, June 25, 2025
Recce Pharmaceuticals Ltd. is engaged in the research and development of pharmaceutical drugs that kill germs. It produces antibiotics that are effective in attacking disease-causing Gram-positive and Gram-negative bacteria. The company was founded on April 11, 2007 and is headquartered in Sydney, Australia.
asx-rce
Market Cap
AU$96.60M
Volume
84673
Open
0.29
AU$
High
0.32
AU$
Low
0.29
AU$
Shares On Issue
231M
52 Week Low
0.275
AU$
52 Week High
0.614
AU$
Website
www.recce.com.au
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report
Related
Our friendly team is here to help.
If you have any questions or feedback about our service, please feel free to contact us.
© Australian Stock Report Pty Ltd. All rights reserved